Bortezomib and pyrexia Patient Reports February 12, 2012

Bortezomib Side Effects Report #5782965-9
Bortezomib side effect was reported by a Health Professional from UNITED STATES on June 19, 2008. Male patient, weighting 170.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: diarrhoea, ileus paralytic, pyrexia, vomiting. Bortezomib dosage: 1.3 MG/M3 DAY 1, 4, 8, 11 IV. During the same period patient was treated with BENDAMUSTINE, RITUXIMAB. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5809716-3
Bortezomib side effect was reported by a Consumer or non-health professional from UNITED STATES on July 11, 2008. Male patient, child 6 years of age, weighting 51.15 lb, was diagnosed with neuroblastoma  and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: neutropenia, pyrexia. Bortezomib dosage: 1.04MG, D1,4,8,11, IV MAY + JUNE, 4DAYS/MONTH. During the same period patient was treated with IRINOTECAN, CEFPODOXIME PROXETIL, HEPARIN, IMODIUM, OXYCODON, POTASSIUM IODIDE, PRILOSEC, ZOFRAN. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5793070-X
Bortezomib side effect was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2008. Male patient, weighting 50.30 lb, was diagnosed with neuroblastoma  and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: bacillus infection, blood culture positive, pyrexia. Bortezomib dosage: 1.04 MG D1, 4, 8, 11 IV. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5819093-X
Bortezomib side effect was reported by a Consumer or non-health professional from UNITED STATES on July 21, 2008. Male patient, weighting 50.30 lb, was diagnosed with neuroblastoma  and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: bacillus infection, blood culture positive, catheter related infection, pyrexia. Bortezomib dosage: 1.04 MG D1, 4, 8, 11. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.


Bortezomib Side Effects Report #5749576-2
Bortezomib side effect was reported by a Health Professional from UNITED STATES on May 20, 2008. Male patient, 74 years of age, weighting 167.0 lb, was diagnosed with mantle cell lymphoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: cardiac failure, dyspnoea at rest, dyspnoea exertional, ejection fraction decreased, pleural effusion, pneumonia , pulmonary oedema, pyrexia. Bortezomib dosage: 2.4MG D1+4 IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXAN, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5145980-4
Bortezomib side effect was reported by a Health Professional from UNITED STATES on Nov 06, 2006. Male patient, 63 years of age, weighting 229.3 lb, was diagnosed with mantle cell lymphoma and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: decubitus ulcer, pancytopenia, pyrexia. Bortezomib dosage: 3 MG D1 AND 4 IV. During the same period patient was treated with CYCLOPHOSPHAMIDE, RITUXAN, DOXORUBICIN, DEXAMETHASONE, VINCRISTINE. Patient was hospitalized. Patient recovered.

Bortezomib Side Effects Report #5841096-X
Bortezomib side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 11, 2008. Female patient, weighting 137.3 lb, was diagnosed with hla marker study positive and was treated with Bortezomib. After drug was administered, patient experienced the following side effects: pyrexia. Bortezomib dosage: 2.3MG ONCE IV. Patient was hospitalized. Patient recovered.